in chronically HBV-infected patients on nucleos(t)ide therapy. About Virion Therapeutics (Virion) Virion Therapeutics, LLC is a clinical-stage company developing novel T cell-based ...

Virion Therapeutics COO Dr Sue Currie said: “Finding a treatment for chronic HBV-infected patients will almost assuredly require an immune-based component to help control the infection.

Twenty-seven patients with Chronic Hepatitis B Virus infection (CHB) have now been dosed with VRON-0200 as a single (Prime), or Prime and Boost, intramuscular (i.m.) injection ...

[16–18] Emergence of drug resistance hinders long-term use of NAs. AT-61; AT-130 Inhibit HBV virion production by inappropriate assembly of capsids (no clinical data available yet) Induces ...

AT-61; AT-130 Inhibit HBV virion production by inappropriate assembly of capsids (no clinical data available yet) Induces structural changes in HBV capsids; initiates virion assembly at wrong ...